MedPath

Burn Validation Study

Completed
Conditions
Wounds and Injuries
Burns
Wound Heal
Interventions
Device: DeepView SnapShot Portable (DV-SSP)
Registration Number
NCT06131203
Lead Sponsor
SpectralMD
Brief Summary

The purpose of this study is to validate the algorithm for burn healing assessment by the Spectral MD DeepView device which would provide burn healing potential assessment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
274
Inclusion Criteria

Willing and able to give informed consent or have a Legally Authorized Representative (LAR) able to do so; Life expectancy > 6 months; Thermal burn mechanism (flame, scald, or contact); The Study Burn(s) occurred less than 72 hours prior to the time of first imaging; and Minimum burn wound size for adult or pediatric patients is 0.5% TBSA per region For adult Subjects: Have 2 - 4 regions of their clinical burn(s) that meet the criteria for a Study Burn.

For pediatric Subjects: Have 1 - 4 regions of their clinical burn(s) that meet the criteria for a Study Burn

Exclusion Criteria

Burn pattern distribution isolated to head, face, neck, hands, feet, genitalia, and/or joints; Subject has burns involving > 50% total body surface area (TBSA); Sepsis at the time of enrollment; Immunosuppression/radiation/chemotherapy < 3 months prior to enrollment; Concurrent use of investigational products with a known effect on the burn sites; and/or Any condition that in the opinion of the Investigator may prevent compliance with the study requirements or compromise subject safety.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Emergency Department Burn SubjectsDeepView SnapShot Portable (DV-SSP)Subjects with Thermal Burn Injury enrolled through the emergency department
Burn Center Burn SubjectsDeepView SnapShot Portable (DV-SSP)Subjects with Thermal Burn Injury enrolled through the burn center
Primary Outcome Measures
NameTimeMethod
Primary BC Endpoint3 weeks

Demonstrate the DeepView AI-Burns' sensitivity is superior to BC HCPs' bedside examination while maintaining non-inferior specificity to burn HCPs.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (21)

Valleywise Health

🇺🇸

Phoenix, Arizona, United States

Shriners Children's Northern California

🇺🇸

Sacramento, California, United States

University of California Davis Health

🇺🇸

Sacramento, California, United States

University of California San Diego

🇺🇸

San Diego, California, United States

MedStar Washington Hospital Center

🇺🇸

Washington DC, District of Columbia, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

University of Iowa

🇺🇸

Iowa City, Iowa, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

University of Louisville

🇺🇸

Louisville, Kentucky, United States

University Medical Center

🇺🇸

New Orleans, Louisiana, United States

University of Rochester

🇺🇸

Rochester, New York, United States

SUNY Stony Brook Medical Center

🇺🇸

Stony Brook, New York, United States

University of North Carolina Chapel Hill

🇺🇸

Chapel Hill, North Carolina, United States

Akron Children's Hospital

🇺🇸

Akron, Ohio, United States

Ohio State University

🇺🇸

Columbus, Ohio, United States

St. Christopher's Children Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

MUSC Shawn Jenkins Children's Hospital

🇺🇸

Charelston, South Carolina, United States

Texas Tech University

🇺🇸

Lubbock, Texas, United States

University of Utah Health

🇺🇸

Salt Lake City, Utah, United States

Virginia Commonwealth University

🇺🇸

Richmond, Virginia, United States

University of Washington Harborview

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath